Clinical Trial Update: Safety of Photodynamic Therapy (PDT) in the Ablation of High-grade Dysplasia (HGD) in Barrett's Esophagus (BE) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating safety of photodynamic therapy to ablate high-grade dysplasia in Barrett's esophagus has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Barrett Esophagus

Snippet

Sponsor: Pinnacle Biologics Inc. | Conditions: Barrett Esophagus | Phase 3 | Status: WITHDRAWN